Medical Marijuana Not Approved to Treat Opioid Withdrawal

Print icon

On Monday, Feb. 26, the state Board of Physicians tabled a proposal to add opioid use disorder and opioid withdrawals to Connecticut’s list of approved medical marijuana conditions, citing a need to further consult with mental health and addiction experts.

The Board considered three other chronic conditions and diseases at the public hearing in Hartford, approving one, rejecting one, and tabling two, including opioid use and withdrawals. There are currently 22 conditions that qualify adults for medical marijuana in Connecticut, with more than 23,000 registered patients.

According to J. Craig Allen, MD, medical director at Rushford and a board certified addiction medicine doctor, the treatment of opioid use disorder with medical marijuana carries many risks.

“There is no evidence that cannabis is an effective treatment for opioid use disorder,” Allen said. “But, there is significant research showing that addictive substances like marijuana, alcohol and cocaine impact the same neuro-circuitry that is dysfunctional in opioid use disorder leading to decreased inhibition, impaired judgment and increased vulnerability to relapse.”

Another concern, according to Allen, is that adding opioid use disorder to Connecticut’s approved conditions would draw people away from the evidence-based,  FDA-approved, first-line options like medication-assisted treatment.

“Medication-assisted treatment is  already highly underutilized,” Allen said. “Medications such as Suboxone or Vivitrol provide protection from overdose at the level of the opioid receptor; marijuana doesn’t do that. Without this protection, people are at a much higher risk of relapsing and potentially overdosing and dying.”

Whether cannabis or cannabinoids have any role in the treatment of someone suffering from opioid addiction is yet to be determined. However, a study in the January edition of “The American Journal of Psychiatry” concluded that cannabis use appears to increase rather than decrease the risk of developing nonmedical prescription opioid use and opioid use disorder. 

“As is the case with most proposed medical uses of cannabis, more research needs to be done in order to determine efficacy and safety,” Allen said. “At this point, we need to be cautious and collect more information before moving forwards with any decisions about opioids and medical marijuana.”



What's New

Flu Season

Here’s What’s in Your Flu Vaccine: Will It Work This Season?

Wasn’t it just yesterday that we were sunning ourselves at Hammonasset Beach? Actually, yes it was, but now it’s officially fall and we only care about one thing — the coming flu season. Predicting the severity of a flu season isn’t like predicting which team will win more football games, the...

Heart & aspirin.

Baby Aspirin a Day for Your Heart? Not For Everyone

While about 50 percent of older American adults take aspirin regularly to ward off heart disease, a new study reveals that the practice may actually cause more harm than good for healthy people. Dr. Paul Thompson, chief of cardiology and physician co-director of the Hartford HealthCare Heart & Vascular Institute,...


Study: MitraClip Device a ‘Game-Changer’ for Heart-Failure Patients

Until now, patients with serious heart failure caused by leaky valves were treated so they felt a little better but the disease relentlessly stunted their life expectancy relentlessly. Recent research published in the New England Journal of Medicine, however,  gives hope to these patients, according to Dr. Sabet Hashim, chair...


Report: Up to 75 Percent of Patients Don’t Take Meds as Prescribed

“Devastating” and “staggering (toll)” are adjectives used by officials with the National Council for Behavioral Health’s Medical Director Institute, or MDI, on its recent report showing a grave lack of compliance to medication prescriptions. Noncompliance with medication regimens — when people do not take prescription drugs as prescribed by their...

Kids, Social Media and Body Image

Raising teens to have a positive body image isn’t easy. And it seems to have become more complicated in the age of Snapchat and Instagram, where selfies can be filtered to perfection. Plastic surgeons have even reported that patients are visiting their practices with filtered social media images and asking...

Assessing the Hereditary Risk of Cancer

A new hereditary cancer risk assessment program is helping identify specific cancers in women and men across Connecticut. Hartford HealthCare nurse practitioner Meghan Burgess explains the importance of this program. Q: Why is it so important to have this type of assessment program? A: We’re identifying women at risk for...

What is Precision Medicine in Breast Cancer Treatment?

Precision medicine allows doctors to treat patients based on their individual biology. Dr. Camelia Lawrence is the director of breast surgery at the Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut and MidState Medical Center. She explains how precision medicine is used in treating breast cancer.  Q: What is precision medicine? A:...